A study conducted by Seufert J et al. [25] demonstrated that switching the basal insulin to Gla-300 in basal insulin supported oral regimen improved metabolic control and treatment satisfaction with a decreased risk of symptomatic and nocturnal hypoglycemia and without weight gain. This evidence concerns the gene INS and Hypoglycemia.